Table 1 Clinical details of cases of CSE according to initial benzodiazepine treatment
|
LZP only
|
DZP only
|
Both
|
| Total number of episodes |
17 |
46 |
9 |
| Number eCSE:pCSE |
6:11 |
25:21 |
6:3 |
| Mean age in years (range) |
46.9 (17–84) |
51.8 (20–88) |
51.8 (25–78) |
| Sex (M:F) |
10:7 |
30:16 |
4:5 |
| Known epileptics (n (%)) |
12 (70) |
37 (80) |
8 (88) |
| Identified aetiology/precipitants* (n (%)) |
10 (59) |
33 (71) |
6 (66) |
| Alcohol |
5 (29) |
18 (39) |
3 (33) |
| Poor compliance |
3 (18) |
13 (28) |
4 (44) |
| CNS infection |
1 (6) |
1 (2) |
0 (0) |
| Cerebrovascular disease |
0 (0) |
2 (4) |
0 (0) |
| Other** |
4 (23) |
8 (17) |
1 (11) |
| Mean duration prior to first treatment*** (range) |
45 (30–90) |
59 (15–315) |
45 (10–120) |
|
LZP, lorazepam; DZP, diazepam; *Some patients had more than one identified factor. **Includes systemic infection; subdural haemorrhage; toxic; metabolic; multiple sclerosis. ***eCSE cases only (some DZP patients were treated prior to arrival in A&E).
